Dan Donovan

Mr. Donovan served as a Director and Chief Business Officer of Cancer Prevention Pharmaceuticals, Inc., until June 2022, bringing his vision of successful development and commercialization methodologies in rare diseases to CPP. Mr. Donovan is also CEO of rareLife Solutions, Inc, a company he co-founded in 2014.